Argon Medical announced in June that it has formalised a Medical Advisory Board comprised of distinguished physicians from institutions across the USA who specialise in interventional medicine. The Medical Advisory Board will continue to provide scientific and clinical expertise to guide the organisation in planning and implementing product development initiatives and marketing programs with the goal of improving the lives of patients and their caregivers, a press release from the company states.
Argon welcomes seven members to the Medical Advisory Board: James F Benenati, Miami Cardiac and Vascular Institute, Miami; Jim Caridi, Tulane University Medical Center, New Orleans; Matthew S Johnson, Indiana University Health, Indianapolis; John A Kaufman, Oregon Health and Science University, Portland; John Moriarty, UCLA Medical Center, Santa Monica; Robert K Ryu, University of Colorado Hospital, Aurora; and David W Trost, Weill Medical College of Cornell University, New York.
“We are very pleased to introduce the founding members of Argon’s Medical Advisory Board. Their knowledge and expertise in interventional procedures provide a unique and unparalleled perspective, which helps us drive innovation to meet customer needs,” said George Leondis, president and CEO of Argon.
